Bladder Cancer Tissue Study in Muscle-Invasive Patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been part of a specific prior study or be planning to have your bladder removed as part of standard care.
- You must have a type of bladder cancer called urothelial carcinoma (the most common kind).
- You must be in good general health (able to do daily activities with little or no help).
- Your cancer must have grown into the muscle layer of the bladder (stage T2, T3, or T4) and not have spread to lymph nodes or other organs.
- You must have tumor tissue and blood samples from the start of your treatment available for the study.
- You cannot be in this study if you refuse to take part in the linked trials or if your samples are not available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue from bladder cancer surgeries to understand how immune cells and surrounding tissue interact. It may help find better ways to treat bladder cancer in the future, but it does not involve new treatments for participants.
This study looks at how well a standard chemotherapy given before surgery works for muscle-invasive bladder cancer. It aims to see if higher responses lead to better outcomes.
This trial tests giving chemotherapy before surgery to remove the bladder, to see if it can improve outcomes for patients with muscle-invasive bladder cancer. The treatment is personalized based on a lab test of your tumor cells, which may help make the therapy more effective.
This study uses a special PET/CT scan to see how far your bladder cancer has spread. The results may help doctors plan the best treatment for you.
This trial tests if adding a special CT scan before bladder removal helps find muscle-invasive bladder cancer earlier. It includes people with different stages of bladder cancer who are planning to have their bladder removed.
This trial uses a blood test to look for small pieces of tumor DNA (ctDNA) after treatment for muscle-invasive bladder cancer. It aims to find out if the test can detect leftover or returning cancer earlier, helping guide next steps.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.